Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized Trial of Liposomal Prednisolone (LIPMAT) to Enhance Radiocephalic Fistula Maturation: A Pilot Study.
Voorzaat BM, van der Bogt KEA, Bezhaeva T, van Schaik J, Eefting D, van der Putten K, van Nieuwenhuizen RC, Groeneveld JO, Hoogeveen EK, van der Meer IM, Statius van Eps RG, Vogt L, Huisman L, Gabreëls BATF, Boom H, Verburgh CA, Boon D, Metselaar JM, Weijmer MC, Rotmans JI. Voorzaat BM, et al. Among authors: van der putten k. Kidney Int Rep. 2020 Jun 5;5(8):1327-1332. doi: 10.1016/j.ekir.2020.05.030. eCollection 2020 Aug. Kidney Int Rep. 2020. PMID: 32775836 Free PMC article. No abstract available.
Improvement of radiocephalic fistula maturation: rationale and design of the Liposomal Prednisolone to Improve Hemodialysis Fistula Maturation (LIPMAT) study - a randomized controlled trial.
Voorzaat BM, van Schaik J, van der Bogt KE, Vogt L, Huisman L, Gabreëls BA, van der Meer IM, van Eps RG, Eefting D, Weijmer MC, Groeneveld HO, van Nieuwenhuizen RC, Boom H, Verburgh CA, van der Putten K, Rotmans JI. Voorzaat BM, et al. Among authors: van der putten k. J Vasc Access. 2017 Mar 6;18(Suppl. 1):114-117. doi: 10.5301/jva.5000673. Epub 2017 Mar 5. J Vasc Access. 2017. PMID: 28297049 Clinical Trial.
Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
Emans ME, Braam B, Diepenbroek A, van der Putten K, Cramer MJ, Wielders JP, Swinkels DW, Doevendans PA, Gaillard CA. Emans ME, et al. Among authors: van der putten k. Kidney Blood Press Res. 2012;36(1):344-54. doi: 10.1159/000343392. Epub 2012 Dec 12. Kidney Blood Press Res. 2012. PMID: 23235391 Free article. Clinical Trial.
Answer to Photoquiz Does it bite?
Boon GJAM, van der Putten K, van Hattem JM, Heidt J. Boon GJAM, et al. Among authors: van der putten k. Neth J Med. 2020 Jul;78(4):215. Neth J Med. 2020. PMID: 32641556 Free article. No abstract available.
[A skin lesion with ghost cells].
Markusse IM, Velstra B, van der Putten K. Markusse IM, et al. Among authors: van der putten k. Ned Tijdschr Geneeskd. 2017;161:D1285. Ned Tijdschr Geneeskd. 2017. PMID: 28745246 Dutch.
Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients.
van der Putten K, Jie KE, van den Broek D, Kraaijenhagen RJ, Laarakkers C, Swinkels DW, Braam B, Gaillard CA. van der Putten K, et al. Among authors: van den broek d. Eur J Heart Fail. 2010 Sep;12(9):943-50. doi: 10.1093/eurjhf/hfq099. Epub 2010 Jul 3. Eur J Heart Fail. 2010. PMID: 20601671 Free article. Clinical Trial.
25 results